Apheresis to Mitigate Atherosclerotic Vascular Disease-Reference-Cited by-同舟云学术

Apheresis to Mitigate Atherosclerotic Vascular Disease

Published:2018-07-16 Issue:8 Volume:31 Page:945-949
ISSN:0895-7061
Container-title:American Journal of Hypertension
language:en
Short-container-title:

Author:

Sachais Bruce S¹,Shaz Beth H¹^ORCID

Affiliation:

1. New York Blood Center, New York, New York, USA

Publisher

Oxford University Press (OUP)

Subject

Internal Medicine

Link

http://academic.oup.com/ajh/article-pdf/31/8/945/25166573/hpy068.pdf

Reference34 articles.

1. Guidelines on the use of therapeutic apheresis in clinical practice-evidence-based approach from the writing committee of the American Society for Apheresis: the Seventh Special Issue;Schwartz;J Clin Apher,2016

2. Grades of recommendation for antithrombotic agents: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th edition);Guyatt;Chest,2008

3. Lipoprotein apheresis: present and future uses;Moriarty;Curr Opin Lipidol,2015

4. Lipoprotein apheresis;Bhoj;Curr Atheroscler Rep,2015

5. HELP LDL apheresis reduces plasma pentraxin 3 in familial hypercholesterolemia;Zanetti;PLoS One,2014

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cardiovascular Disease in Anti-neutrophil Cytoplasm Antibody-Associated Vasculitis;Current Rheumatology Reports;2023-11-28

2. Lipoprotein(a)—60 Years Later—What Do We Know?;Cells;2023-10-17

3. There is urgent need to treat atherosclerotic cardiovascular disease risk earlier, more intensively, and with greater precision: A review of current practice and recommendations for improved effectiveness;American Journal of Preventive Cardiology;2022-12

4. Apheresis for severe hypercholesterolaemia and elevated lipoprotein(a);Pathology;2019-02